Quantcast

Latest G protein-coupled receptor Stories

2015-01-23 04:20:55

LONDON and BOSTON, January 23, 2015 /PRNewswire/ -- Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, is delighted

2014-12-15 04:20:47

LONDON and BOSTON, December 15, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, is pleased to announce

2014-11-20 12:31:06

LONDON and BOSTON, November 20, 2014 /PRNewswire/ -- Project to develop first-in-class selective and orally available GLP-1 receptor antagonist for treating severe

2014-09-16 04:21:23

LONDON and BOSTON, September 16, 2014 /PRNewswire/ -- Heptares Therapeutics notes that its Chief Scientific Officer, Fiona Marshall, will give a presentation entitled "Structure-based

2014-09-03 08:33:44

Experienced Financial and Operational Leader to Support Global Development of Novel Monoclonal Antibody Therapeutics to GPCRs LA JOLLA, Calif. and SHANGHAI, Sept.

2014-06-30 04:21:39

LONDON and BOSTON, June 30, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, is delighted to announce

2014-06-24 12:28:56

LONDON and BOSTON, June 24, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that its President,


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related